Can Sexual Activity Reduce Disability in Men With Early Parkinson Disease?
For male patients with Parkinson disease, sexual activity is associated with lower motor and nonmotor disability.
Movement Disorders
FDA Accepts Opicapone NDA for Adjunctive Treatment of Parkinson Disease
Neurocrine Biosciences announced that the Food and Drug Administration has accepted the New Drug Application for opicapone.
PR001 Gets Fast Track Status for Parkinson Disease With GBA1 Mutation
The FDA has granted Fast Track designation to PR001 (Prevail Therapeutics) for the treatment of Parkinson disease patients with a GBA1 mutation (PD-GBA).
Suicidal Behavior Seen After Deep Brain Stimulation for Parkinson Disease
In patients with Parkinson disease who receive subthalamic nucleus deep brain stimulation, suicide behaviors tend to occur during the first 3 years after the procedure.
DAT Availability Indicates Risk for Cognitive Impairment, Depression in Newly Diagnosed PD
Researchers find caudate quantification of DAT availability shortly after diagnosis may have an important role in identifying patients at risk for clinical progression to cognitive impairment, depression, and gait problems in the near future.
Recommendations for Screening and Rating Impulse Control Disorders in Parkinson Disease
International Parkinson’s and Movement Disorder Society released recommendations on clinical screening instruments and rating scales used to measure impulsive and compulsive behaviors in Parkinson disease.
Antiviral Therapy May Reduce Risk for Parkinson Disease in Chronic HCV
Investigators sought to determine the risk for Parkinson disease development in patients with hepatitis C virus who received antiviral treatment and in patients who did not receive this treatment.
Parkinson Disease Risk Increased in Bipolar Disorder
More frequent manic/mixed and depressive episodes were associated with an increased risk for Parkinson disease.
Certain Infections Associated with Higher Rates of Parkinson Disease
Certain viral and bacterial infections are associated with higher rates of Parkinson disease.
Distinct Features in PD With vs Without Central Parkinsonian Pain
Patients with Parkinson disease with vs without central parkinsonian pain may be younger, have earlier disease onset, fewer comorbidities, and greater pain relief with antiparkinsonian therapies.
Next post in Movement Disorders
